BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

507 related articles for article (PubMed ID: 30526315)

  • 21. Evaluation of Cell-Free Synthesized Human Channel Proteins for In Vitro Channel Research.
    Nishiguchi R; Tanaka T; Hayashida J; Nakagita T; Zhou W; Takeda H
    Membranes (Basel); 2022 Dec; 13(1):. PubMed ID: 36676855
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Flavonoids as Modulators of Potassium Channels.
    Richter-Laskowska M; Trybek P; Delfino DV; Wawrzkiewicz-Jałowiecka A
    Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674825
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Structure-based discovery and in vitro validation of inhibitors of chloride intracellular channel 4 protein.
    Olotu F; Medina-Carmona E; Serrano-Sanchez A; Ossa F; El-Hamdaoui A; Bishop ÖT; Ortega-Roldan JL; Abdul-Salam VB
    Comput Struct Biotechnol J; 2023; 21():688-701. PubMed ID: 36659928
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Apolipoprotein L1 (APOL1) cation current in HEK-293 cells and in human podocytes.
    Vandorpe DH; Heneghan JF; Waitzman JS; McCarthy GM; Blasio A; Magraner JM; Donovan OG; Schaller LB; Shah SS; Subramanian B; Riella CV; Friedman DJ; Pollak MR; Alper SL
    Pflugers Arch; 2023 Mar; 475(3):323-341. PubMed ID: 36449077
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fragment-based computational design of antibodies targeting structured epitopes.
    Aguilar Rangel M; Bedwell A; Costanzi E; Taylor RJ; Russo R; Bernardes GJL; Ricagno S; Frydman J; Vendruscolo M; Sormanni P
    Sci Adv; 2022 Nov; 8(45):eabp9540. PubMed ID: 36367941
    [TBL] [Abstract][Full Text] [Related]  

  • 26. ATP-Sensitive Potassium Channels in Migraine: Translational Findings and Therapeutic Potential.
    Clement A; Guo S; Jansen-Olesen I; Christensen SL
    Cells; 2022 Aug; 11(15):. PubMed ID: 35954249
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Potassium Channels as a Target for Cancer Therapy: Current Perspectives.
    Zúñiga L; Cayo A; González W; Vilos C; Zúñiga R
    Onco Targets Ther; 2022; 15():783-797. PubMed ID: 35899081
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Targeting Lipid-Ion Channel Interactions in Cardiovascular Disease.
    Hudgins EC; Bonar AM; Nguyen T; Fancher IS
    Front Cardiovasc Med; 2022; 9():876634. PubMed ID: 35600482
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ligand-Gated Ion Channels as Targets for Treatment and Management of Cancers.
    Rao R; Shah S; Bhattacharya D; Toukam DK; Cáceres R; Pomeranz Krummel DA; Sengupta S
    Front Physiol; 2022; 13():839437. PubMed ID: 35350689
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Baroreceptors in the Aortic Arch and Their Potential Role in Aortic Dissection and Aneurysms.
    Reutersberg B; Pelisek J; Ouda A; de Rougemont O; Rössler F; Zimmermann A
    J Clin Med; 2022 Feb; 11(5):. PubMed ID: 35268252
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Circulating Tumor Cells: Does Ion Transport Contribute to Intravascular Survival, Adhesion, Extravasation, and Metastatic Organotropism?
    Stock C
    Rev Physiol Biochem Pharmacol; 2022; 182():139-175. PubMed ID: 35137308
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A Versatile Clustered Regularly Interspaced Palindromic Repeats Toolbox to Study Neurological Ca
    Tsortouktzidis D; Tröscher AR; Schulz H; Opitz T; Schoch S; Becker AJ; van Loo KMJ
    Front Mol Neurosci; 2021; 14():667143. PubMed ID: 35069110
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Monoclonal Human Antibodies That Recognise the Exposed N and C Terminal Regions of the Often-Overlooked SARS-CoV-2 ORF3a Transmembrane Protein.
    Tan TH; Patton E; Munro CA; Corzo-Leon DE; Porter AJ; Palliyil S
    Viruses; 2021 Nov; 13(11):. PubMed ID: 34835009
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fluorescence Approaches for Characterizing Ion Channels in Synthetic Bilayers.
    Islam MS; Gaston JP; Baker MAB
    Membranes (Basel); 2021 Nov; 11(11):. PubMed ID: 34832086
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quantitative prediction model for affinity of drug-target interactions based on molecular vibrations and overall system of ligand-receptor.
    Wang XR; Cao TT; Jia CM; Tian XM; Wang Y
    BMC Bioinformatics; 2021 Oct; 22(1):497. PubMed ID: 34649499
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anti-Inflammatory Effect of Licochalcone A via Regulation of ORAI1 and K
    Phan HTL; Kim HJ; Jo S; Kim WK; Namkung W; Nam JH
    Int J Mol Sci; 2021 Oct; 22(19):. PubMed ID: 34639190
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antibodies Targeting K
    Hernandez-Resendiz I; Hartung F; Pardo LA
    Bioelectricity; 2019 Sep; 1(3):180-187. PubMed ID: 34471820
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cancer Salt Nostalgia.
    Allu AS; Tiriveedhi V
    Cells; 2021 May; 10(6):. PubMed ID: 34064273
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Therapeutic Antibodies Targeting Potassium Ion Channels.
    Bednenko J; Colussi P; Hussain S; Zhang Y; Clark T
    Handb Exp Pharmacol; 2021; 267():507-545. PubMed ID: 33963460
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mini-review: antibody therapeutics targeting G protein-coupled receptors and ion channels.
    Hutchings CJ
    Antib Ther; 2020 Dec; 3(4):257-264. PubMed ID: 33912796
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.